Source: Pharmaceutical Business Review
Date: February 14, 2007
Summary:
BrainStorm Cell Therapeutics has begun a safety trial using its adult stem cell technology in an animal model of Parkinson's disease. The company's adult stem cell technology has proven effective in animal models of Parkinson's disease in previous preclinical trials.
